TC
TEVA icon

TAP Consulting’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

TAP Consulting’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-186
Closed -$1K – 495
2021
Q4 		$1K Buy
+186
New +$1.68K ﹤0.01% 547

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Abrams Capital Management
Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return
Menora Mivtachim Holdings
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
Migdal Insurance & Financial Holdings
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Clal Insurance
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
Phoenix Financial
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Harel Insurance Investments & Financial Services
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

TAP Consulting's TEVA Position: Q1 2022 in Review

TAP Consulting sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q1 2022, closing a stake of 186 shares — an estimated $1K sold.

TAP Consulting first reported a position in TEVA in Q4 2021 and held it in 1 quarter. The position peaked at $1K in Q4 2021. 438 funds tracked by Wall St. Rank hold TEVA as of Q1 2022.

  • TAP Consulting reported no remaining Teva Pharmaceutical Industries Limited position as of Q1 2022 after selling out during the quarter.
  • TAP Consulting sold 186 Teva Pharmaceutical Industries Limited shares in Q1 2022, an estimated $1K.
  • TAP Consulting first reported a position in Teva Pharmaceutical Industries Limited in Q4 2021 and held it in 1 quarter.
  • TAP Consulting's Teva Pharmaceutical Industries Limited position peaked at $1K in Q4 2021.
  • 438 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q1 2022.

Based on TAP Consulting's 13F filing for Q1 2022, filed 26 Apr 2022.